Breakthrough: First Patient Vaccinated Against Skin CancerWed 1st May, 2024In the midst of the COVID-19 pandemic, mRNA vaccination has emerged as a revolutionary approach. Now, this groundbreaking technology holds promise in the fight against skin cancer. However, the risk of skin cancer recurrence remains considerable. Harnessing the mRNA Vaccine from the COVID-19 Pandemic for Skin Cancer TreatmentThe most severe form of skin cancer, malignant melanoma, is the target of the mRNA vaccine jointly developed by Moderna and MSD. Skin cancer, the most widespread cancer type, claims many lives annually.
